nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2D6—Parkinson's disease	0.428	0.583	CbGaD
Buprenorphine—ABCB1—Parkinson's disease	0.306	0.417	CbGaD
Buprenorphine—OPRM1—telencephalic ventricle—Parkinson's disease	0.00492	0.0887	CbGeAlD
Buprenorphine—OPRL1—brainstem—Parkinson's disease	0.00379	0.0683	CbGeAlD
Buprenorphine—OPRL1—forebrain—Parkinson's disease	0.00366	0.0659	CbGeAlD
Buprenorphine—OPRM1—nerve—Parkinson's disease	0.0031	0.0559	CbGeAlD
Buprenorphine—OPRL1—spinal cord—Parkinson's disease	0.00236	0.0425	CbGeAlD
Buprenorphine—OPRL1—head—Parkinson's disease	0.00209	0.0377	CbGeAlD
Buprenorphine—OPRL1—nervous system—Parkinson's disease	0.00199	0.0358	CbGeAlD
Buprenorphine—OPRL1—central nervous system—Parkinson's disease	0.00191	0.0344	CbGeAlD
Buprenorphine—OPRD1—forebrain—Parkinson's disease	0.00188	0.0339	CbGeAlD
Buprenorphine—OPRK1—forebrain—Parkinson's disease	0.00181	0.0325	CbGeAlD
Buprenorphine—Methylnaltrexone—CYP2D6—Parkinson's disease	0.00152	0.375	CrCbGaD
Buprenorphine—OPRL1—brain—Parkinson's disease	0.00152	0.0273	CbGeAlD
Buprenorphine—OPRM1—brainstem—Parkinson's disease	0.00133	0.024	CbGeAlD
Buprenorphine—OPRM1—forebrain—Parkinson's disease	0.00129	0.0232	CbGeAlD
Buprenorphine—Oxymorphone—CYP2D6—Parkinson's disease	0.00113	0.28	CrCbGaD
Buprenorphine—OPRD1—head—Parkinson's disease	0.00108	0.0194	CbGeAlD
Buprenorphine—OPRK1—head—Parkinson's disease	0.00103	0.0186	CbGeAlD
Buprenorphine—OPRD1—nervous system—Parkinson's disease	0.00102	0.0184	CbGeAlD
Buprenorphine—OPRD1—central nervous system—Parkinson's disease	0.000985	0.0177	CbGeAlD
Buprenorphine—OPRK1—nervous system—Parkinson's disease	0.000981	0.0177	CbGeAlD
Buprenorphine—OPRK1—central nervous system—Parkinson's disease	0.000944	0.017	CbGeAlD
Buprenorphine—CYP2D6—hindbrain—Parkinson's disease	0.000932	0.0168	CbGeAlD
Buprenorphine—OPRK1—cerebellum—Parkinson's disease	0.000923	0.0166	CbGeAlD
Buprenorphine—OPRM1—midbrain—Parkinson's disease	0.000849	0.0153	CbGeAlD
Buprenorphine—OPRM1—spinal cord—Parkinson's disease	0.000828	0.0149	CbGeAlD
Buprenorphine—Naltrexone—ABCB1—Parkinson's disease	0.000809	0.2	CrCbGaD
Buprenorphine—OPRD1—brain—Parkinson's disease	0.000782	0.0141	CbGeAlD
Buprenorphine—OPRK1—brain—Parkinson's disease	0.00075	0.0135	CbGeAlD
Buprenorphine—OPRM1—head—Parkinson's disease	0.000736	0.0133	CbGeAlD
Buprenorphine—CYP2A6—cerebellum—Parkinson's disease	0.000704	0.0127	CbGeAlD
Buprenorphine—OPRM1—nervous system—Parkinson's disease	0.000698	0.0126	CbGeAlD
Buprenorphine—OPRM1—central nervous system—Parkinson's disease	0.000672	0.0121	CbGeAlD
Buprenorphine—Naloxone—ABCB1—Parkinson's disease	0.00059	0.146	CrCbGaD
Buprenorphine—CYP2C9—cardiovascular system—Parkinson's disease	0.000581	0.0105	CbGeAlD
Buprenorphine—CYP2A6—brain—Parkinson's disease	0.000571	0.0103	CbGeAlD
Buprenorphine—ABCG2—medulla oblongata—Parkinson's disease	0.000543	0.00978	CbGeAlD
Buprenorphine—CYP2D6—brainstem—Parkinson's disease	0.000534	0.00962	CbGeAlD
Buprenorphine—OPRM1—brain—Parkinson's disease	0.000533	0.00961	CbGeAlD
Buprenorphine—CYP2D6—forebrain—Parkinson's disease	0.000515	0.00928	CbGeAlD
Buprenorphine—ABCG2—midbrain—Parkinson's disease	0.000496	0.00894	CbGeAlD
Buprenorphine—ABCG2—spinal cord—Parkinson's disease	0.000484	0.00872	CbGeAlD
Buprenorphine—ABCB1—embryo—Parkinson's disease	0.000419	0.00755	CbGeAlD
Buprenorphine—ABCG2—cerebellum—Parkinson's disease	0.000384	0.00692	CbGeAlD
Buprenorphine—ABCB1—forebrain—Parkinson's disease	0.000371	0.00668	CbGeAlD
Buprenorphine—CYP2C8—brain—Parkinson's disease	0.000321	0.00578	CbGeAlD
Buprenorphine—ABCB1—cardiovascular system—Parkinson's disease	0.000313	0.00565	CbGeAlD
Buprenorphine—ABCG2—brain—Parkinson's disease	0.000312	0.00562	CbGeAlD
Buprenorphine—CYP2D6—head—Parkinson's disease	0.000295	0.00531	CbGeAlD
Buprenorphine—CYP3A4—nervous system—Parkinson's disease	0.000284	0.00512	CbGeAlD
Buprenorphine—CYP2D6—nervous system—Parkinson's disease	0.00028	0.00504	CbGeAlD
Buprenorphine—CYP3A4—central nervous system—Parkinson's disease	0.000274	0.00493	CbGeAlD
Buprenorphine—CYP2D6—central nervous system—Parkinson's disease	0.000269	0.00485	CbGeAlD
Buprenorphine—ABCB1—medulla oblongata—Parkinson's disease	0.000268	0.00482	CbGeAlD
Buprenorphine—CYP2D6—cerebellum—Parkinson's disease	0.000263	0.00474	CbGeAlD
Buprenorphine—ABCB1—midbrain—Parkinson's disease	0.000245	0.00441	CbGeAlD
Buprenorphine—ABCB1—spinal cord—Parkinson's disease	0.000239	0.0043	CbGeAlD
Buprenorphine—CYP2D6—brain—Parkinson's disease	0.000214	0.00385	CbGeAlD
Buprenorphine—ABCB1—head—Parkinson's disease	0.000212	0.00382	CbGeAlD
Buprenorphine—ABCB1—nervous system—Parkinson's disease	0.000201	0.00362	CbGeAlD
Buprenorphine—ABCB1—central nervous system—Parkinson's disease	0.000194	0.00349	CbGeAlD
Buprenorphine—ABCB1—cerebellum—Parkinson's disease	0.000189	0.00341	CbGeAlD
Buprenorphine—ABCB1—brain—Parkinson's disease	0.000154	0.00277	CbGeAlD
Buprenorphine—CYP2A6—Metabolism—CTGF—Parkinson's disease	2.59e-05	0.000125	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—TH—Parkinson's disease	2.59e-05	0.000125	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTP1—Parkinson's disease	2.59e-05	0.000125	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MAOA—Parkinson's disease	2.58e-05	0.000125	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—DDC—Parkinson's disease	2.58e-05	0.000125	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—TH—Parkinson's disease	2.57e-05	0.000124	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—HMOX1—Parkinson's disease	2.55e-05	0.000123	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	2.54e-05	0.000123	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—DDC—Parkinson's disease	2.51e-05	0.000122	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.5e-05	0.000121	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYCS—Parkinson's disease	2.49e-05	0.00012	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.48e-05	0.00012	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—APOE—Parkinson's disease	2.47e-05	0.00012	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYCS—Parkinson's disease	2.47e-05	0.000119	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	2.46e-05	0.000119	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	2.46e-05	0.000119	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	2.45e-05	0.000119	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ABCB1—Parkinson's disease	2.45e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NGF—Parkinson's disease	2.44e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	2.43e-05	0.000118	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.43e-05	0.000118	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOB—Parkinson's disease	2.43e-05	0.000117	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	2.42e-05	0.000117	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.4e-05	0.000116	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NQO1—Parkinson's disease	2.39e-05	0.000116	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTM1—Parkinson's disease	2.38e-05	0.000115	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.37e-05	0.000115	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.37e-05	0.000115	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.37e-05	0.000114	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—TH—Parkinson's disease	2.36e-05	0.000114	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	2.35e-05	0.000114	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—DDC—Parkinson's disease	2.35e-05	0.000114	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	2.33e-05	0.000112	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-05	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.31e-05	0.000112	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GPX1—Parkinson's disease	2.28e-05	0.00011	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYCS—Parkinson's disease	2.26e-05	0.000109	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.24e-05	0.000108	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.23e-05	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.22e-05	0.000107	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—COMT—Parkinson's disease	2.2e-05	0.000107	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTP1—Parkinson's disease	2.19e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.19e-05	0.000106	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MAOA—Parkinson's disease	2.19e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—COMT—Parkinson's disease	2.19e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTP1—Parkinson's disease	2.18e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MAOA—Parkinson's disease	2.17e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.17e-05	0.000105	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—HMOX1—Parkinson's disease	2.16e-05	0.000105	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APOE—Parkinson's disease	2.16e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—HMOX1—Parkinson's disease	2.15e-05	0.000104	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.14e-05	0.000103	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NGF—Parkinson's disease	2.14e-05	0.000103	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.12e-05	0.000102	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—INS—Parkinson's disease	2.11e-05	0.000102	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.11e-05	0.000102	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.11e-05	0.000102	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.11e-05	0.000102	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTHFR—Parkinson's disease	2.1e-05	0.000102	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.08e-05	0.000101	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ABCB1—Parkinson's disease	2.08e-05	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.06e-05	9.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ABCB1—Parkinson's disease	2.06e-05	9.95e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	2.06e-05	9.95e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.05e-05	9.89e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	2.04e-05	9.84e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTM1—Parkinson's disease	2.02e-05	9.75e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.01e-05	9.74e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—DDC—Parkinson's disease	2.01e-05	9.7e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—COMT—Parkinson's disease	2e-05	9.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2e-05	9.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2e-05	9.65e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.99e-05	9.64e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.99e-05	9.64e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.99e-05	9.62e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.99e-05	9.61e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.98e-05	9.56e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.97e-05	9.5e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	1.97e-05	9.5e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—APOE—Parkinson's disease	1.96e-05	9.45e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GPX1—Parkinson's disease	1.93e-05	9.33e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.91e-05	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.91e-05	9.21e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.9e-05	9.16e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOE—Parkinson's disease	1.89e-05	9.14e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.89e-05	9.12e-05	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—Parkinson's disease	1.89e-05	9.12e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.89e-05	9.11e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.88e-05	9.09e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.87e-05	9.05e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TH—Parkinson's disease	1.86e-05	8.98e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—INS—Parkinson's disease	1.84e-05	8.91e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.83e-05	8.86e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NGF—Parkinson's disease	1.81e-05	8.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.81e-05	8.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.78e-05	8.62e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—Parkinson's disease	1.78e-05	8.61e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.77e-05	8.57e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.77e-05	8.54e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GPX1—Parkinson's disease	1.75e-05	8.48e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.72e-05	8.31e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.71e-05	8.25e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.69e-05	8.17e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—INS—Parkinson's disease	1.67e-05	8.07e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—Parkinson's disease	1.66e-05	8.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.65e-05	7.98e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—Parkinson's disease	1.64e-05	7.95e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.63e-05	7.89e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—Parkinson's disease	1.62e-05	7.83e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—INS—Parkinson's disease	1.62e-05	7.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	7.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TH—Parkinson's disease	1.61e-05	7.78e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.61e-05	7.77e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—Parkinson's disease	1.6e-05	7.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.58e-05	7.65e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—COMT—Parkinson's disease	1.58e-05	7.64e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.57e-05	7.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.57e-05	7.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.57e-05	7.58e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.55e-05	7.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.55e-05	7.49e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.55e-05	7.47e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.54e-05	7.46e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—Parkinson's disease	1.51e-05	7.29e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.49e-05	7.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.47e-05	7.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.47e-05	7.1e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.46e-05	7.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.46e-05	7.04e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.45e-05	7.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.44e-05	6.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.44e-05	6.97e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.44e-05	6.95e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TH—Parkinson's disease	1.44e-05	6.94e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.42e-05	6.88e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—INS—Parkinson's disease	1.42e-05	6.85e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—INS—Parkinson's disease	1.4e-05	6.79e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TH—Parkinson's disease	1.4e-05	6.78e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.38e-05	6.69e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.38e-05	6.67e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	1.37e-05	6.63e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—COMT—Parkinson's disease	1.37e-05	6.61e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—INS—Parkinson's disease	1.37e-05	6.6e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	1.36e-05	6.59e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.36e-05	6.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.36e-05	6.57e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	6.55e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.35e-05	6.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.34e-05	6.5e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.34e-05	6.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.34e-05	6.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.33e-05	6.42e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TH—Parkinson's disease	1.32e-05	6.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	6.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TH—Parkinson's disease	1.31e-05	6.33e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.3e-05	6.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.29e-05	6.23e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—INS—Parkinson's disease	1.29e-05	6.22e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.28e-05	6.17e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.27e-05	6.13e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	6.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.26e-05	6.08e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	6.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.25e-05	6.05e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.23e-05	5.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—COMT—Parkinson's disease	1.22e-05	5.9e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.22e-05	5.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.21e-05	5.86e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	1.2e-05	5.82e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.2e-05	5.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.2e-05	5.79e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	1.2e-05	5.78e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—COMT—Parkinson's disease	1.19e-05	5.76e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—Parkinson's disease	1.19e-05	5.75e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.19e-05	5.73e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.18e-05	5.72e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.17e-05	5.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.15e-05	5.56e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	5.55e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.14e-05	5.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.12e-05	5.43e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TH—Parkinson's disease	1.12e-05	5.41e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.12e-05	5.4e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.12e-05	5.4e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.12e-05	5.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.11e-05	5.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.11e-05	5.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.11e-05	5.35e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	1.11e-05	5.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.11e-05	5.34e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.1e-05	5.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.09e-05	5.28e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.09e-05	5.27e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.07e-05	5.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.07e-05	5.17e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.06e-05	5.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.05e-05	5.07e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.04e-05	5.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—Parkinson's disease	1.03e-05	4.98e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.03e-05	4.97e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.02e-05	4.92e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.02e-05	4.92e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—INS—Parkinson's disease	1.02e-05	4.91e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.01e-05	4.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.87e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX1—Parkinson's disease	9.84e-06	4.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.75e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.69e-06	4.68e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—Parkinson's disease	9.64e-06	4.66e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—COMT—Parkinson's disease	9.52e-06	4.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.51e-06	4.6e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	9.47e-06	4.58e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOA—Parkinson's disease	9.45e-06	4.57e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	9.35e-06	4.52e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	9.34e-06	4.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—Parkinson's disease	9.19e-06	4.44e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.08e-06	4.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9e-06	4.35e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—Parkinson's disease	8.97e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.97e-06	4.33e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.86e-06	4.28e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—INS—Parkinson's disease	8.8e-06	4.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.76e-06	4.24e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.7e-06	4.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TH—Parkinson's disease	8.64e-06	4.17e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—Parkinson's disease	8.45e-06	4.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—Parkinson's disease	8.38e-06	4.05e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX1—Parkinson's disease	8.34e-06	4.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.29e-06	4.01e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—Parkinson's disease	8.05e-06	3.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INS—Parkinson's disease	7.85e-06	3.79e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.69e-06	3.72e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INS—Parkinson's disease	7.66e-06	3.7e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—COMT—Parkinson's disease	7.34e-06	3.55e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.31e-06	3.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.29e-06	3.52e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INS—Parkinson's disease	7.22e-06	3.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.21e-06	3.48e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—Parkinson's disease	7.16e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INS—Parkinson's disease	7.16e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—Parkinson's disease	7.06e-06	3.41e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.92e-06	3.34e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.72e-06	3.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.43e-06	3.11e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INS—Parkinson's disease	6.12e-06	2.96e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—Parkinson's disease	5.97e-06	2.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.94e-06	2.87e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—Parkinson's disease	5.53e-06	2.67e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INS—Parkinson's disease	4.72e-06	2.28e-05	CbGpPWpGaD
